Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Chenghui Li and Sajjad Bhatti.
|
|
Connection Strength |
|
|
|
|
|
0.685 |
|
|
|
-
Mahashabde RV, Bhatti SA, Martin BC, Painter JT, Rodriguez A, Ying J, Li C. Immune checkpoint inhibitors as subsequent treatment in older adults with non-small cell lung cancer and synchronous brain metastases. Transl Lung Cancer Res. 2024 Jul 30; 13(7):1620-1634.
Score: 0.246
-
Mahashabde R, Bhatti SA, Martin BC, Painter JT, Rodriguez A, Ying J, Li C. Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non-Small-Cell Lung Cancer and Synchronous Brain Metastases. JCO Oncol Pract. 2023 11; 19(11):1009-1019.
Score: 0.232
-
Li C, Bhatti SA, Ying J. Immune Checkpoint Inhibitors-Associated Cardiotoxicity. Cancers (Basel). 2022 Feb 23; 14(5).
Score: 0.208